Global Peptide Therapeutics Market Size & Outlook
Global peptide therapeutics market, 2018-2030 (US$M)
Related Markets
Global peptide therapeutics market highlights
- The global peptide therapeutics market generated a revenue of USD 43,452.8 million in 2023 and is expected to reach USD 66,413.0 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 6.2% by 2030.
- In terms of segment, metabolic disorders accounted for a revenue of USD 16,424.8 million in 2023.
- Metabolic disorders is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Spain is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 43,452.8 million |
| Market revenue in 2030 | USD 66,413.0 million |
| Growth rate | 6.2% (CAGR from 2023 to 2030) |
| Largest segment | Metabolic disorders |
| Fastest growing segment | Metabolic disorders |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cancer, Metabolic disorders, Cardiovascular disorders, Respiratory disorders, Gastrointestinal disorders, Infectious disease, Pain, Dermatological disorders, Neurological disorders, Renal disorders |
Other key industry trends
- In terms of revenue, the North America accounted for 45.6% of the global peptide therapeutics market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Spain is the fastest growing regional market and is projected to reach USD 1,265.3 million by 2030.
Metabolic disorders was the largest segment with a revenue share of 37.8% in 2023. Horizon Databook has segmented the Global peptide therapeutics market based on cancer, metabolic disorders, cardiovascular disorders, respiratory disorders, gastrointestinal disorders, infectious disease, pain, dermatological disorders, neurological disorders, renal disorders covering the revenue growth of each sub-segment from 2018 to 2030.
The global peptide therapeutics market is expected to grow at a lucrative rate over the forecast period as companies are focusing on the development of new drugs. Various companies are involved in extensive to develop novel drugs for treatment of target diseases to increase their market shares.
For instance, Sanofi is working on phase 3 clinical trials of Efpeglenatide, a long-lasting glucagon-like peptide-1 (GLP-1) diabetes molecule. The study is aimed at assessing the safety and efficacy of the treatment candidate. The in peptide therapeutics is majorly focused on metabolic disorders m followed by oncology and infectious diseases. This is expected to propel the market growth over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Peptide Therapeutics Market Scope
Peptide Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global peptide therapeutics market statistics, by regions, 2018-2030 (US$M)
Top 10 countries: Peptide therapeutics market size, 2023 (USD Million)
Top 10 countries: Peptide therapeutics market size, 2023 (USD Million)
Global peptide therapeutics market, by region, 2023 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
